8MoΒ·

Oscar Health Q4’25 EARNINGS HIGHLIGHTS

$OSCR (-1,31Β %)


πŸ”Ή Revenue: $2.81B (Est. $3.11B) πŸ”΄

πŸ”Ή EPS: ($1.24) (Est. ($0.89)) πŸ”΄


FY26 Guide (Raise):

πŸ”Ή Revenue: $18.7B–$19.0B (Est. $12.756B) 🟒

πŸ”Ή MLR: 82.4%–83.4%

πŸ”Ή SG&A Expense Ratio: 15.8%–16.3%

πŸ”Ή Earnings from Ops: $250M–$450M


Other Metrics:

πŸ”Ή Total Members: 2,042,449 (as of Dec 31, 2025)

πŸ”Ή Individual and Small Group Members: 2,042,449 (as of Dec 31, 2025)


Financials:

πŸ”Ή Q4 Total Revenue: $2,805.235M

πŸ”Ή Q4 MLR: 95.4%

πŸ”Ή Q4 SG&A Expense Ratio: 18.2%

πŸ”Ή Q4 Loss from Ops: ($333.747M)

πŸ”Ή Q4 Net Loss attributable to Oscar: ($352.611M)

πŸ”Ή Q4 Adj. EBITDA: ($307.782M)


Other Events:

πŸ”Ή Revolving Credit Facility: $475M secured 3-year revolver (entered Feb 6, 2026)


πŸ”Ή Data conflict: Membership shows β€œ~3.4M” in your note vs β€œ2,042,449” in the financial tables (as of Dec 31, 2025)


Commentary:

πŸ”Έ β€œ2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026.”

πŸ”Έ β€œ...drove record-high membership – positioning us to achieve significantly improved financial performance in 2026.”

πŸ”Έ β€œWe took opportunistic steps to strengthen our balance sheet and optimize our capital structure.”

5
Participez Γ  la conversation